Burning Rock Biotech Limited
BNR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$1 | -$1 | -$1 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -4% | -4.6% | 10.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 70.3% | 67.6% | 67.5% | 71.7% |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | -52.4% | -96.4% | -152% | -147% |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -67.2% | -121.6% | -172.4% | -156.9% |
| EPS Diluted | -33.67 | -63.84 | -93.47 | -76.45 |
| % Growth | 47.3% | 31.7% | -22.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$1 |